HIV Produkte
(Human Immunodeficiency Virus (HIV))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Empfohlene HIV Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human Immunodeficiency Virus (HIV)
Applikation
ELISA, IF, WB
Validierungen
Kat. Nr.
ABIN5688577
Menge
0.1 mg
Datenblatt
Datenblatt
Reaktivität
Human Immunodeficiency Virus (HIV)
Applikation
ELISA, IF, WB, IHC
Validierungen
Kat. Nr.
ABIN5688572
Menge
0.1 mg
Datenblatt
Datenblatt
Reaktivität
Human Immunodeficiency Virus (HIV)
Applikation
ELISA, WB
Validierungen
Kat. Nr.
ABIN5688571
Menge
0.1 mg
Datenblatt
Datenblatt
Empfohlene HIV ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Lentivirus
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (25)
Kat. Nr.
ABIN2345178
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Human
Analytical Method
Qualitative
Validierungen
Kat. Nr.
ABIN5520522
Menge
96 tests
Datenblatt
Datenblatt
Empfohlene HIV Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human Immunodeficiency Virus (HIV)
Source
Human Cells
Validierungen
- (1)
Kat. Nr.
ABIN7320989
Menge
50 μg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren HIV Produkten
: "Screening of HIV-1 Protease Using a Combination of an Ultra-High-Throughput Fluorescent-Based Assay and RapidFire Mass Spectrometry." in: Journal of biomolecular screening, Vol. 20, Issue 5, pp. 606-15, (2015) (PubMed).: "Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease." in: EMBO molecular medicine, Vol. 7, Issue 5, pp. 510-25, (2015) (PubMed).
: "Use of a Novel Integrase-Deficient Lentivirus for Targeted Anti-Cancer Therapy With Survivin Promoter-Driven Diphtheria Toxin A." in: Medicine, Vol. 94, Issue 31, pp. e1301, (2015) (PubMed).
: "Central memory CD4+ T cells are preferential targets of double infection by HIV-1." in: Virology journal, Vol. 12, pp. 184, (2015) (PubMed).
: "Foxa2 acts as a co-activator potentiating expression of the Nurr1-induced DA phenotype via epigenetic regulation." in: Development (Cambridge, England), Vol. 141, Issue 4, pp. 761-72, (2014) (PubMed).
: "The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events." in: Journal of virology, Vol. 88, Issue 18, pp. 10803-12, (2014) (PubMed).
: "CD4+ memory stem cells are infected by HIV-1 in a manner regulated in part by SAMHD1 expression." in: Journal of virology, Vol. 88, Issue 9, pp. 4976-86, (2014) (PubMed).
: "Apoptotic cell death and altered calcium homeostasis caused by frataxin depletion in dorsal root ganglia neurons can be prevented by BH4 domain of Bcl-xL protein." in: Human molecular genetics, Vol. 23, Issue 7, pp. 1829-41, (2014) (PubMed).
: "Interferon alfa partially inhibits HIV replication in hepatocytes in vitro." in: The Journal of infectious diseases, Vol. 208, Issue 5, pp. 865-6, (2013) (PubMed).
: "A combination HIV reporter virus system for measuring post-entry event efficiency and viral outcome in primary CD4+ T cell subsets." in: Journal of virological methods, Vol. 195, pp. 164-9, (2013) (PubMed).
Haben Sie etwas anderes gesucht?
- Histone H4ac
- Histone H4
- Histone H3.3C
- Histone H3.3B
- Histone H3.3
- Histone H3.3
- Histone H3.1
- Histone H3.1
- Histone H2B Type 1-C/E/F/G/I
- Histone H2B 7
- Histone H2B 5
- Histone H2B
- Histone H2A.2
- Histone H2A Variant H2A.Z, Pht1
- Histone H2A Variant
- Histone H2A type 1-J
- Histone H2A
- Histone H1.5
- Histone H1.3
- Histone H1.1
Sie sind hier:
